Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Altius Institute for Biomedical Sciences is an independent, non-profit research organization focused on decoding the human genome's regulatory operating system. The institute utilizes advanced high-throughput technologies to map the regulatory DNA landscape across hundreds of human cell and tissue types to understand how genes are controlled in health and disease. By integrating deep computational biology with innovative experimental platforms, Altius aims to identify new therapeutic targets and develop next-generation medicines, including gene and cell therapies. The organization is notable for its large-scale industrial-style approach to biological discovery and its significant strategic collaborations with major pharmaceutical companies like GSK.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Altius.